Payers, Manufacturers Await Federal Vaccine Rollout Plan With Chart: How Close Are We to a Coronavirus Vaccine?

As the many COVID-19 vaccines under development barrel toward clinical trials for safety and efficacy (see infographic,below), questions remain about how they will be distributed when they become available. Payers and PBMs will likely play a critical role in vaccine rollout, but what that will entail is not yet clear. In large part, that’s because both the health insurance industry and pharmaceutical manufacturers are waiting on a vaccine distribution plan from the federal government.

According to Anthony Fauci, M.D., head of the National Institute of Allergy and Infectious Diseases, drug manufacturing firms will coordinate closely with the government to distribute vaccine doses.

0

0

0 Comments

0

0

• Radar on Drug Benefits